Key result
Class I antiarrhythmic drugs appear to preferentially bind closed cardiac sodium channels to prevent sodium influx.
Why the study?
Despite widespread use of Class I antiarrhythmic drugs, understanding of their mechanism of action on cardiac sodium channels remains incomplete.
Describes the mechanistic model of Class I antiarrhythmic drugs binding preferentially to the closed state of cardiac sodium channels.
Answers are grounded in this paper and cite their sources.
May refine in vitro sodium channel models; leaves open clinical translation for Class I antiarrhythmics.
The major electrophysiological effect of Class I antiarrhythmic drugs is blockade of the cardiac sodium channel, thereby reducing the initial depolarization of the action potential and slowing impulse propagation. Despite the widespread use of these drugs our understanding of their mechanism of action is incomplete. Models based on electrophysiological studies predict that a receptor for Class I drugs is associated with the sodium channel, and that occupancy of this receptor causes blockade of the sodium channel. Recent radioligand studies with [3H]batrachotoxinin-A benzoate have identified a binding site for Class I drugs associated with rat cardiac myocyte sodium channels, which may be the predicted receptor. Binding of drugs to this site is saturable, reversible, stereospecific, and occurs at pharmacologically relevant concentrations with similar rank order of potency in vivo and in vitro. Drugs appear to bind preferentially to a closed state of the channel, thereby preventing channel opening and subsequent sodium influx.
No takes yet. Share an insight, caveat, or question.
Sheldon et al. (1989) reported a review. Class I antiarrhythmic drugs was evaluated. Class I antiarrhythmic drugs appear to bind preferentially to a closed state of the cardiac sodium channel, preventing channel opening and subsequent sodium influx.
Synapse has enriched 10 related papers. Consider them for comparative context: